A Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics, and determine the maximum tolerated dose of ZSP1241 in participants with hepatocellular carcinoma, cholangiocarcinoma, gastric cancer, esophageal cancer, colorectal cancer and other advanced solid tumors.
创建时间：
2018-11-15
